Rather, dividing humanity into racial groupings, pharmaceutical companies come across as caring about specific characteristics to which a group of individuals can relate and with which they closely identify. All of this results in the commodification and reification of race.
Mental disorders have become a global commodity. A diagnostic fad heavily promoted first in the US now quickly spreads around the world; and multinational corporations have perfected the profitable art of international marketing.
We are seeking to hold the pharmaceutical companies who manufacture these drugs accountable for what we now believe was a methodically-executed plan to deceive doctors and patients into over-prescribing opioids.
The good news is that the number of Americans who are uninsured (without health insurance) dropped eight percent in the first quarter of 2014 compared to the same period in 2013. The bad news is that this means 41 million Americans are not insured.
We need to readjust the way we educate physicians. Young doctors need to understand money more clearly from the start (especially the $200,000 in school loans part). But they must also grasp the hypocrisy that tells them that medical businesses, like Pharma, are inherently evil.
If Ebola continued as confined outbreaks for a limited time, a patent for a drug to treat it, or a vaccine to prevent it, might not feed the corporate bottom line. So we have waited for a desperate crisis when a cure might bring enough profit to light up the bottom line.
Since private property and freedom of contract are the core of the free market, we assume drug companies have every right to charge what they want for the property they sell. Yet in reality the "free market" can't be separated from government because government determines the rules of the game.
While not all relationships between health care providers and drug and medical device manufacturers are problematic, the implementation of the Physician Payments Sunshine Act will help ensure that provider-industry relationships finally receive appropriate scrutiny.
Nothing is more damaging to research than funding instability. The universities and many research laboratories -- including those run by the government -- operate like concertinas. They expand and contract according the whim of Congress.
Tough as it is, having highly effective, but expensive, new treatments is a good problem to have. These drugs mean longer, better lives for humans the world over. We need to foster competitive markets and public policies that enable us to benefit.
The night when impotence first crossed my mind announced my fall from grace as a man. I was 14 years old, a blissful stranger to the histrionics of the male erection. My own was something I took for granted.